Syncell
PrivateLast Round
Series A
Jul 23, 2025
Total Funding Raised
$60.22M
Company Overview
Syncell operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Series A round in July 2025.
Syncell is a life science technology company that provides a spatial proteomics platform, Microscoop®, designed for high-precision, unbiased discovery of the proteome at the cellular and subcellular level.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syncell Comparables
Compare Syncell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pixelgen Technologies | 82% | |
| Resolve Biosciences | 81% | |
| Vizgen | 73% |
For institutional investors. Book with your work email.
Syncell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 23, 2025 | ||||
| Series A | Dec 11, 2024 | ||||
| Seed | Oct 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Syncell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Seed |
| Diamond BioFund | Seed |
| Ta Ya Electric Wire & Cable | Seed |
| Taiwania Capital | Series A |
| Abico Group | Series A |
| TA YA VENTURE HOLDINGS LIMITED | Series A |
| Everbright Biofund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2023
$4M round led by Diamond BioFund.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 28, 2026
Syncell Inc. introduces the Microscoop platform, a spatial proteomics technology that integrates microscopy with targeted photolabeling to characterize proteins within intact biological specimens.
For institutional investors. Book with your work email.
Syncell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Syncell's valuation, stock price, and market status.
Is Syncell a public or private company?
Syncell is a private company.
What is the current stock price of Syncell?
Syncell is a private company, so its shares have no public market price. Caplight tracks Syncell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Syncell worth (valuation)?
Valuation information for Syncell is not publicly available.
Can I buy Syncell stock?
Syncell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Syncell's last funding round?
Syncell's most recent funding round was Series A on July 23, 2025.
Who are the main investors in Syncell?
Key investors in Syncell include Diamond BioFund, Taiwania Capital.
Will Syncell IPO soon?
No public IPO plans have been announced for Syncell.
How can I track Syncell secondary market activity?
Caplight tracks bids, offers, and trades in Syncell's shares on secondary markets.